The research team, led by investigators at Anhui Medical University, turned to the Ma’anshan birth cohort, a longitudinal study that has followed children from birth with repeated measurements of body length or height and weight at every follow-up visit. Rather than treating growth as a series of isolated snapshots, the scientists modeled each child’s body mass index trajectory as a continuous curve spanning the first years of life. This approach allowed them to extract eleven distinct growth markers, including the timing and magnitude of the adiposity peak in infancy, the timing and level of the adiposity rebound in early childhood, the steepness of growth slopes during infancy, toddlerhood, and the preschool and school-age periods, and the cumulative area under the BMI curve across each developmental window.

Two of these markers deserve particular attention because they encode milestones that pediatricians have watched for decades. The adiposity peak is the point in the first year or so of life when a baby’s BMI reaches its maximum before naturally declining. The adiposity rebound, first described in the 1980s by French researchers as a simple predictor of later obesity, marks the moment when the BMI curve bottoms out and begins climbing again. An early rebound has long been associated with elevated obesity risk, but the new study goes further by embedding these milestones within a comprehensive, quantitative portrait of each child’s growth across the entire early life course.

To characterize growth patterns rather than individual markers alone, the team applied k-means clustering, an unsupervised machine learning technique that groups children according to the overall similarity of their BMI trajectories. This data-driven classification revealed distinct growth archetypes within the cohort, some of which corresponded to persistently high or rapidly rising BMI across multiple developmental stages. When the researchers examined cardiometabolic outcomes at school age, including waist circumference, blood pressure, blood glucose, and blood lipids, the differences between these archetypes proved striking. Children in high-risk growth patterns were significantly more likely to display clustered cardiometabolic risk factors, a composite indication of emerging metabolic syndrome.

The numbers are arresting. Among boys, membership in a high-risk growth pattern was associated with a relative risk of 6.75 for clustered cardiometabolic risk factors, with a 95 percent confidence interval of 3.81 to 12.92. Among girls, the relative risk climbed to 8.34, with a confidence interval of 4.15 to 18.69. In practical terms, a child whose early growth curve resembles a high-risk archetype faces several times the odds of exhibiting the combined metabolic warning signs, such as central adiposity alongside elevated blood pressure, glucose, or adverse lipid profiles, compared with a child on a low-risk trajectory. Crucially, when the researchers stratified their analyses by obesity status, the associations remained significant, suggesting that the information encoded in growth patterns is not simply a proxy for whether a child is currently obese.

Ten of the eleven growth markers showed significant associations with clustered cardiometabolic risk in both boys and girls. The lone exception was the age at adiposity peak, whose association proved to be sex-specific, a nuance the authors highlight as evidence that growth-related risk may unfold differently along biological sex lines. The remaining markers, spanning the BMI values at peak and rebound, the timing of the rebound, the slopes of BMI gain in infancy, toddlerhood, and later childhood, and the cumulative BMI exposure measured as area under the curve in each period, all carried statistical weight. This breadth implies that no single developmental window holds a monopoly on risk; instead, cardiometabolic vulnerability appears to accumulate across the life course, from the first months of infancy through the transition into school age.

The statistical machinery behind these conclusions reflects the growing sophistication of life-course epidemiology. The team fitted childhood BMI growth curves using linear mixed modeling, a framework well suited to the irregular, repeated measurements that characterize real-world cohort data. The analysis was carried out with the EGGLA R package, an open-source tool for growth curve modeling that the authors make available on GitHub, lowering the barrier for other research groups to adopt the same methodology. By combining flexible curve fitting with clustering and conventional risk estimation, the study demonstrates how modern computational tools can convert routine pediatric measurements, the kind recorded at every well-child visit, into clinically meaningful risk stratification.

What makes the findings compelling is their grounding in a prospective birth cohort rather than retrospective recall. The Ma’anshan birth cohort has collected anthropometric data from birth onward, meaning the growth curves were constructed from measurements taken as children developed, not reconstructed years later. At school age, the same children underwent direct assessment of cardiometabolic risk factors, creating a temporal chain from early growth to measurable health outcomes. The study was approved by the Committee of Bio-Medical Ethics of Anhui Medical University, and informed consent was obtained from all participants. The cohort itself has been previously described in the International Journal of Epidemiology, and earlier analyses from the same group have examined how birth outcomes and early growth relate to the age at adiposity rebound.

The broader context sharpens the urgency of this work. Cardiovascular disease remains the leading cause of death worldwide, and projections published in the European Journal of Preventive Cardiology anticipate a rising global burden through mid-century. Risk factors that were once considered adult problems, including hypertension, dyslipidemia, and type 2 diabetes, are increasingly documented in children and adolescents, and long-running cohort studies such as Bogalusa have shown that childhood BMI and blood pressure cast long shadows into midlife, influencing adult dyslipidemia, diabetes, and even left ventricular structure. Against this backdrop, identifying modifiable or at least detectable signals in early childhood becomes a public health priority, and growth trajectories are among the most accessible signals available.

The authors conclude that childhood growth patterns and markers across different phases of the life course are closely tied to cardiometabolic health, and they argue that monitoring growth trajectories from infancy onward could enable earlier identification of children at elevated risk. In an era when childhood overweight and obesity are projected to keep climbing globally, the message is that the growth chart pinned to a pediatrician’s wall may be one of the most underused predictive instruments in preventive medicine. A child’s curve, read carefully and early, may whisper warnings about the heart long before any symptom appears, offering families and clinicians a window for intervention measured not in decades but in the crucial first years of life.

Subject of Research: Impact of growth markers and patterns of growth on children’s cardiometabolic health: a life course perspective

Article Title: Impact of growth markers and patterns of growth on children’s cardiometabolic health: a life course perspective

Article References: Luo, L., Tong, J., Wang, X., Huang, Q.-Z., Liu, Y.-K., Lv, P., Wang, J., Geng, C., Gao, H., Gan, H., Geng, M.-L., Zhu, B.-B., Tao, S.-M., Wu, X.-Y., Huang, K., Yan, S.-Q., & Tao, F.-B. (2026). Impact of growth markers and patterns of growth on children’s cardiometabolic health: a life course perspective. World Journal of Pediatrics. https://doi.org/10.1007/s12519-026-01072-z

Image Credits: AI Generated

DOI: 10.1007/s12519-026-01072-z

Keywords: Impact, growth, markers, patterns, children, cardiometabolic, health, life, course, perspective, scientific research

Epigenetics, the study of chemical modifications that regulate gene expression without altering the underlying DNA sequence, has increasingly become a focal point in understanding how prenatal and early life environments influence long-term health outcomes. The particular modifications examined in this study are methyl groups that attach to DNA strands and either activate or silence gene expression. By scrutinizing these methylation marks within imprint control regions—genomic areas critical to regulating gene activity during development—the researchers have identified robust correlations between these early-life epigenetic signatures and metabolic dysfunction metrics measured years later.

The study involved 38 children from the Newborn Epigenetics Study, a well-established longitudinal birth cohort in North Carolina, whose umbilical cord blood was collected at birth and subsequently analyzed using advanced molecular techniques to detect methylation changes. These children underwent extensive health evaluations between ages 7 and 12, which included measuring body mass index (BMI), liver fat content, serum alanine transaminase (ALT) levels, triglyceride concentrations, blood pressure readings, and waist-to-hip ratios. By integrating this longitudinal health data with epigenetic maps, the researchers pinpointed specific genetic loci where methylation changes strongly associate with metabolic health indicators.

Among the most striking findings, altered methylation in the gene TNS3 was linked to heightened liver fat accumulation, elevated ALT—a liver enzyme indicative of inflammation or damage—and increased waist-to-hip ratio, all established markers of metabolic distress. Meanwhile, methylation shifts in other genes such as GNAS and CSMD1 exhibited relationships with blood pressure regulation, additional liver enzyme levels, and body fat distribution. These discoveries highlight putative biological pathways that might underlie the onset of metabolic syndrome and related disorders, suggesting a prenatal imprinting of disease risk.

The implications of these findings are profound and multifaceted. As Dr. Ashley Jowell of Duke University Health System, the study’s lead author, explains, “Detecting epigenetic signatures at birth that predispose to metabolic diseases provides a window of opportunity for early intervention well before clinical symptoms manifest.” This capability could revolutionize pediatric care by enabling clinicians to stratify infants according to their inherited risk profiles and tailor preventive strategies—from nutritional counseling to targeted pharmacological approaches—over the child’s developmental course.

Furthermore, co-author Dr. Cynthia Moylan adds nuance to these discoveries by underscoring the influence of the prenatal environment, such as maternal nutrition and health status, on establishing these epigenetic marks. “These methylation patterns are not deterministic but reflect an interplay between genetics and environment during critical periods of fetal development,” she notes. This dynamic suggests that optimizing maternal health during pregnancy could be a powerful lever in modulating disease risk programmed into newborns’ genomes.

Despite the relatively modest sample size, the research team emphasizes that the associations observed are statistically robust and provide a targeted rationale for larger, more definitive studies now underway, funded by the National Institutes of Health. By expanding the cohort and including diverse populations, future research aims to validate and refine these epigenetic biomarkers, elucidate causal mechanisms, and ultimately facilitate their integration into clinical practice.

It is important to recognize that while epigenetic marks serve as predictive signals, they do not equate to immutable destinies. As Dr. Jowell candidly states, “Possessing these markers does not mean disease is inevitable. Rather, it means we have a chance to intervene proactively, potentially altering the child’s health outcomes through surveillance and lifestyle modifications.” This paradigm shift emphasizes prevention and personalized medicine, leveraging molecular biology advances to anticipate and mitigate chronic disease burdens.

The technical methodology underpinning this study involves bisulfite sequencing—a gold standard in methylation analysis—that enables quantification of methyl group attachment at single-base resolution across the genome. By focusing on imprint control regions, which are parent-of-origin-specific regulatory sequences critical for normal development, the researchers isolated epigenetic variations that persist through embryogenesis and influence gene expression in tissues integral to metabolism. This precision allows for interpreting molecular data in the context of physiological and clinical endpoints.

Moreover, integrating multi-omics data—including health metrics and genetic profiles—provides a holistic framework for understanding the complex genesis of metabolic diseases. This systems biology approach aligns with growing recognition that diseases such as non-alcoholic fatty liver disease and hypertension arise from cumulative genetic, epigenetic, and environmental interactions rather than simple Mendelian inheritance.

As the largest global convening of gastroenterology, hepatology, and related disciplines, Digestive Disease Week® 2025 offers the perfect platform for disseminating these transformative insights. The researchers’ presentation, scheduled for May 4, aims to foster collaborations that accelerate translation from bench to bedside, facilitating development of early screening tools and preventive therapeutics tailored to children’s unique epigenetic profiles.

In conclusion, this pioneering research underscores the potential of umbilical cord blood as a minimally invasive reservoir of molecular information, serving as a crystal ball predicting susceptibility to chronic metabolic diseases. By unveiling early-life epigenetic markers linked to later metabolic health, the study lays crucial groundwork for a new era in preventive pediatrics—one where biology-informed foresight empowers families and clinicians to enact timely interventions that may dramatically improve lifelong wellbeing.

Subject of Research: Epigenetic markers in umbilical cord blood predicting metabolic dysfunction in children
Article Title: Epigenetic Insights from Umbilical Cord Blood Reveal Early Predictors of Childhood Metabolic Disease
News Publication Date: April 25, 2025
Web References: https://ddw.org/, http://www.ddw.org/press
Keywords: DNA regions, Clinical research, Research on children, Umbilical cord, Blood, Genetic medicine